Sales & Marketing News | pharmaphorum

News

Innovent gets OK for China's first home-grown IL-23p19 drug

Innovent has picked up approval in China for Pecondle, its anti-IL-23p19 antibody, as a treatment for moderate-to-severe plaque psoriasis.

News

Tonix launches its new fibromyalgia drug in US

Tonix has launched its fibromyalgia therapy Tonmya in the US, the first new drug for the painful condition in more than 16 years.

News

Graphic of man flying a white flag against a teal background

Lundbeck bows out of bidding war for Avadel

Lundbeck won't raise its offer to buy Avadel any further, clearing the way for the sleep disorder specialist to complete a merger with Alkermes.

News

Novo Nordisk files Wegovy product that claimed rapid voucher

Novo Nordisk is using its recently awarded FDA priority voucher on a high-strength version of its obesity drug Wegovy.

News

Sanofi's Paris HQ raided in tax fraud probe

Sanofi's headquarters in Paris has been raided as part of an investigation into a financing deal, said to be related to a historical acquisition.

News

Otsuka joins IgAN market with Voyxact approval in US

Otsuka has claimed FDA approval for its IgAN therapy Voyxact, joining an increasingly crowded market and beating rival Vera Therapeutics to the punch.

Innovent gets OK for China's first home-grown IL-23p19 drug

Tonix launches its new fibromyalgia drug in US

Lundbeck bows out of bidding war for Avadel

Novo Nordisk files Wegovy product that claimed rapid voucher

Sanofi's Paris HQ raided in tax fraud probe

Otsuka joins IgAN market with Voyxact approval in US

Lilly UK recruits ex-England cricketer as obesity champion

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks